A 50% drop after announcement of an offering is not normal. 50% drop post offering is not normal either but is more common with certain kinds of stocks. You can see from the chart below this behavior is new to SINT. Neither phenomenon were the result of anything negative that was happening with Sintx. The fact that i was warned to sell before this began further shows this was done on purpose. The chart you like to post TA actually shows theres something unnatural going on with the stock. Before the 100:1 RS SINT traded pretty well in that channel, which is a clue in itself someones have been manipulating the stock. The accelerated dropping of the stock (in the yellow area) while revenue was growing for Sintx, makes it very obvious. Thats what the SEC needs to investigate.
https://i.imgur.com/xMRDE8n.jpeg
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies